Search

Search Results

• 

  Back to the future: a case series on revisiting onabotulinumtoxinA for chronic migraine management after anti-CGRP therapies failure

  Davide Mascarella, Benedetto Carandente, Valentina Favoni, Elisa Maria Bruno, Pietro Cortelli, Giulia Pierangeli, Sabina Cevoli

  03-12-2024

  Published: 3 December 2024

  548

  PDF: 182
• 

  Intraparenchymal cerebral hemorrhage in a patient undergoing treatment with galcanezumab: the importance of adequate blood pressure control

  Yan Tereshko, Antonio Taglialatela, Iacopo Cancelli, Enrico Belgrado, Lorenzo Verriello, Giovanni Merlino, Mariarosaria Valente

  05-09-2025

  Published: 5 September 2025

  37

  PDF: 17
• 

  Anti-CGRP monoclonal antibodies and migraine with aura: a narrative review

  Danilo Antonio Montisano, Marcella De Luca, Sara Giannoni, Giada Giuliani, Marilena Marcosano, Antonio Munafò, Daniele Pala, Federica Pes, Marina Romozzi, Gabriele Sebastianelli

  12-09-2025

  Published: 12 September 2025

  50

  PDF: 50
• 

  Exploring the cortical effect of monoclonal antibodies against CGRP ligand: a pilot study of the cortical silent period in migraine

  Gabriele Sebastianelli, Giulia Rosaria Melis, Chiara Abagnale, Francesco Casillo, Cherubino Di Lorenzo, Mariano Serrao, Gianluca Coppola

  09-05-2025

  Published: 9 May 2025

  829

  PDF: 155
• 

  Diaphragmatic small bowel disease in a patient with resistant migraine and medication overuse treated with galcanezumab

  Marilena Marcosano, Nicoletta Brunelli, Alessandro Alesina, Luisa Fofi, Claudia Altamura, Fabrizio Vernieri

  23-12-2024

  Published: 23 December 2024

  480

  PDF: 190